Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 10/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.44 |
| ▸ | DGKA | P23743 | 1/20 | 0.44 |
| ▸ | P2RY10 | O00398 | 1/20 | 0.43 |
| ▸ | GPR174 | Q9BXC1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25303134 | 1.00 | EPHX2 (0.47) | EPHX2CNR2MEN1FAAHTP53 | |
| SCHEMBL3357728 | 0.97 | KDM4E (0.48) | EPHX2CNR2MEN1SOAT1KMT2A | |
| SCHEMBL5807418 | 0.94 | CNR1 (0.49) | CNR2MEN1FAAHKMT2ASLC6A5 | |
| SCHEMBL5183216 | 0.93 | DPP7 (0.44) | DGKA | |
| SCHEMBL539143 | 0.93 | DPP7 (0.44) | DGKA | |
| SCHEMBL3283700 | 0.93 | DPP7 (0.44) | DGKA | |
| SCHEMBL3285881 | 0.93 | DPP7 (0.44) | DGKA | |
| SCHEMBL25303264 | 0.93 | DPP7 (0.44) | DGKA | |
| SCHEMBL11052070 | 0.93 | DPP7 (0.44) | DGKA | |
| SCHEMBL1690132 | 0.93 | DPP7 (0.44) | DGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12622967-B2 | Molecules, formulations, and methods for nutritional support of athletes, patients, and others | TODAY, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| US-20240299548-A1 | MOLECULES, FORMULATIONS, AND METHODS FOR NUTRITIONAL SUPPORT OF ATHLETES, PATIENTS, AND OTHERS | TODAY, INC. (US) | 2024-09-12 | — | — | US | disclosed |
| CN-118576561-A | Method for optimizing biocompatible vesicle-coated sinomenine hydrochloride by response surface method | 中国农业大学 | 2024-09-03 | — | — | CN | disclosed |
| US-12023382-B2 | Molecules, formulations, and methods for nutritional support of athletes, patients, and others | Today Inc. (US) | 2024-07-02 | — | — | US | disclosed |
| CN-113710329-B | Personal care compositions | 高露洁-棕榄公司 | 2024-04-05 | — | — | CN | disclosed |
| WO-2023139357-A1 | MOLECULES, NUTRITIONAL FORMULATIONS, AND METHODS OF PROVIDING NUTRITIONAL SUPPORT | Today Inc. (US) | 2023-07-27 | — | — | WO | disclosed |
| US-20230226187-A1 | MOLECULES, FORMULATIONS, AND METHODS FOR NUTRITIONAL SUPPORT OF ATHLETES, PATIENTS, AND OTHERS | Today Inc. (US) | 2023-07-20 | — | — | US | disclosed |
| EP-2399885-A1 | Device and method for solubilizing, separating, removing and reacting carboxylic acids in aqueous or organic solutions by means of micro- or nanoemulsification | Dietz, Ulrich (DE) | 2011-12-28 | — | — | EP | disclosed |
| EP-0964673-B1 | PROTECTIVE AGENTS FOR SKIN AND HAIR | TAKASAGO PERFUMERY CO LTD (JP) | 2003-10-15 | — | — | EP | disclosed |
| US-6355232-B1 | CERAMIDE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-03-12 | — | — | US | disclosed |
| EP-0964673-A4 | PROTECTIVE AGENTS FOR SKIN AND HAIR | TAKASAGO PERFUMERY CO LTD (JP) | 2000-07-05 | — | — | EP | disclosed |
| EP-0964673-A1 | PROTECTIVE AGENTS FOR SKIN AND HAIR | Takasago International Corporation (JP) | 1999-12-22 | — | — | EP | disclosed |
| WO-1998027958-A1 | PROTECTIVE AGENTS FOR SKIN AND HAIR | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1998-07-02 | — | — | WO | disclosed |
| US-5700396-A | OLEIC ACID DERIVATIVES; STORAGE STABILITY | NOF CORPORATION (JP) | 1997-12-23 | — | — | US | disclosed |
| US-5589515-A | CIS-OCTADECENOIC ACID OR DERIVATIVES FOR STORAGE STABILITY IN COSMETICS | NOF CORPORATION (JP) | 1996-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622967-B2 | Molecules, formulations, and methods for nutritional support of athletes, patients, and others | SLC2A9, GYS1, SLC2A8 | EPHX2 4526/4885CNR2 3242/4885MEN1 3204/4885 |
| US-20240299548-A1 | MOLECULES, FORMULATIONS, AND METHODS FOR NUTRITIONAL SUPPORT OF ATHLETES, PATIENTS, AND OTHERS | CPT1B, GK, CPT1A | EPHX2 2875/4885CNR2 201/4885MEN1 2326/4885 |
| US-20230226187-A1 | MOLECULES, FORMULATIONS, AND METHODS FOR NUTRITIONAL SUPPORT OF ATHLETES, PATIENTS, AND OTHERS | CPT1B, GK, CPT1A | EPHX2 2875/4885CNR2 201/4885MEN1 2326/4885 |
| US-12023382-B2 | Molecules, formulations, and methods for nutritional support of athletes, patients, and others | CPT1B, GK, CPT1A | EPHX2 2875/4885CNR2 201/4885MEN1 2326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.